Taikang Asset Management (HK)’s BeOne Medicines Ltd ONC Stock Holding History

Taikang Asset Management (HK)’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,000	Closed	-$1.91M	–	111
2025 Q1	$1.91M	Buy	+7,000	New	+$1.64M	0.26%	86
2024 Q4	–	Sell	-7,000	Closed	-$1.57M	–	121
2024 Q3	$1.57M	Hold	7,000	–	–	0.17%	89
2024 Q2	$999K	Hold	7,000	–	–	0.16%	83
2024 Q1	$1.09M	Hold	7,000	–	–	0.23%	67
2023 Q4	$1.26M	Hold	7,000	–	–	0.24%	59
2023 Q3	$1.26M	Hold	7,000	–	–	0.29%	56
2023 Q2	$1.25M	Hold	7,000	–	–	0.29%	59
2023 Q1	$1.51M	Hold	7,000	–	–	0.27%	58
2022 Q4	$1.54M	Hold	7,000	–	–	0.32%	58
2022 Q3	$944K	Hold	7,000	–	–	0.19%	60
2022 Q2	$1.13M	Hold	7,000	–	–	0.22%	62
2022 Q1	$1.32M	Hold	7,000	–	–	0.22%	63
2021 Q4	$1.9M	Hold	7,000	–	–	0.38%	61
2021 Q3	$2.54M	Hold	7,000	–	–	0.52%	58
2021 Q2	$2.4M	Buy	+7,000	New	+$2.32M	0.37%	67

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Taikang Asset Management (HK)'s ONC Position: Q2 2025 in Review

Taikang Asset Management (HK) sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 7,000 shares — an estimated $1.91M sold.

Taikang Asset Management (HK) first reported a position in ONC in Q2 2021 and held it in 15 quarters. The position peaked at $2.54M in Q3 2021. 245 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

Taikang Asset Management (HK) reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
Taikang Asset Management (HK) sold 7,000 BeOne Medicines Ltd shares in Q2 2025, an estimated $1.91M.
Taikang Asset Management (HK) first reported a position in BeOne Medicines Ltd in Q2 2021 and held it in 15 quarters.
Taikang Asset Management (HK)'s BeOne Medicines Ltd position peaked at $2.54M in Q3 2021.
245 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Taikang Asset Management (HK)'s 13F filing for Q2 2025, filed 13 Aug 2025.